Results 131 to 140 of about 26,990 (251)

Evaluating the Evolving Real‐World Adverse Events of GLP‐1RAs Using FDA Adverse Event Reporting System (FAERS)

Obesity, EarlyView.
Web portal for interrogating Adverse Events of GLP‐1 RA in diabetes vs weight control/obesity. ABSTRACT Objective This study aimed to assess the spectrum and frequency of adverse events (AEs) linked to glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) using the US FDA Adverse Event Reporting System (FAERS).
David Stone, Mary Playdon, Stephen D. Hursting, Aik Choon Tan   +3 more
wiley   +1 more source

Diagnostic and pathophysiological significance of serum myeloperoxidase, ischemia-modified albumin, paraoxonase-1 and galectin-3 in COVID-19 - parallels with myocarditis. [PDF]

BMC Cardiovasc Disord
Dundar A, Cetik Yildiz S, Kabak M, Cil B.   +3 more
europepmc   +1 more source

A Novel Biomarker in Primary Glaucoma: Aqueous Humor and Serum Levels of Ischemia Modified Albumin (IMA). [PDF]

Clin Ophthalmol, 2022
Rusmayani E, Artini W, Sasongko MB, Suhardjo, Viona V.   +4 more
europepmc   +1 more source

P05.03: Ischemia modified albumin in pregnancy [PDF]

Ultrasound in Obstetrics & Gynecology, 2015
A. Rossi, I. Romanello, E. Vogrig, F. Bartiromo, L. Ganzitti, D. Marchesoni   +5 more
openaire   +1 more source

Musculoskeletal Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists Versus Other Antiobesity Agents in Nondiabetic Adults

Obesity, EarlyView.
ABSTRACT Objective This study aimed to evaluate the association of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) with risks of osteoporosis, major osteoporotic fractures, and degenerative musculoskeletal disorders in nondiabetic adults with obesity compared with other obesity medications.
Jie‐Syuan Wu, Lee‐Yuan Lin, Jia‐Wei Sun, Wei‐Ting Yu, Fara Silvia Yuliani, Shyh‐Hsiang Lin   +5 more
wiley   +1 more source

The Role of High-Sensitivity Cardiac Troponin and Ischemia-Modified Albumin in Patients with Lower Extremity Peripheral Arterial Disease. [PDF]

Int J Mol Sci
Boc V, Blinc A, Boc A.
europepmc   +1 more source

Ischemia modified albumin can act as an independent predictor of inhospital mortality in patients with acute aortic dissection. [PDF]

Sci Rep, 2023
Xiang J, He L, Pen T, Wei S.
europepmc   +1 more source

916: Ischemia-modified albumin in pregnancy [PDF]

American Journal of Obstetrics and Gynecology, 2017
Alberto Rossi, Irene Romanello
openaire   +1 more source

SURMOUNT‐REAL UK: A Pragmatic Randomized Clinical Trial to Assess the Effectiveness of Tirzepatide in Adults With Obesity

Obesity, EarlyView.
ABSTRACT Objective SURMOUNT‐REAL UK will evaluate the effectiveness of tirzepatide when offered in addition to standard‐of‐care (SoC) in adults with Class I obesity (BMI ≥ 30 and ≤ 34.9 kg/m2) and without diabetes in a UK primary care setting. Methods A 5‐year, phase 4, multicenter, open‐label, pragmatic randomized clinical trial is enabled through ...
Martin K. Rutter, Julie Mount, J. Martin Gibson, Joanne Webb, Cheryl Marler, Catherine Reed, Mugdha Gore, Wenyu Ye, Elisa Gomez Valderas, John Wilding, Naveed Sattar, Melanie J. Davies, Kamlesh Khunti, Richard Haynes, Rachel L. Batterham   +14 more
wiley   +1 more source

Effects of regular exercise on ischemia-modified albumin and total sulfhydryl levels in young women: a cross-sectional study. [PDF]

Front Physiol
Bilici ÖF, Kahraman MZ, Türker A, Seyhan S, Sahin MF, Demir H, Acar G, Bilici MF, Soylu C, Söğüt T, Bakum A.   +10 more
europepmc   +1 more source